Previous studies reported the anti-inflammatory and immunomodulatory effect of diosmin on the skin keratinocytes in other dermatological diseases such as atopic dermatitis via modulation of Th2 cells activity and the inflammatory cytokines such as IL6 and IL1 (Osman et al. 2022; Feldo et al. 2022). Here, IL1B is linked to atopic eczema.